President Moon: "Government Will Support COVID-19 Vaccine Development Until the End! Absolutely!"

President Moon Jae-in Holds Meeting at Vaccine Development Site

President Moon Jae-in is presiding over the "COVID-19 Vaccine and Treatment Development On-site Meeting" held at SK Bioscience in Seongnam, Gyeonggi Province, a company developing vaccines for the novel coronavirus infection (COVID-19), on the afternoon of the 15th.

President Moon Jae-in visited the site of novel coronavirus disease (COVID-19) vaccine development on the 15th and promised, "The government will be a strong supporter to ensure that vaccines and treatments can be developed by providing full support until the end."

During his visit to the SK Bioscience research center developing the COVID-19 vaccine, President Moon said, "I hope that the pride of the people gained through K-quarantine will continue through K-bio by developing vaccines and treatments, and that the Republic of Korea will establish itself as a beacon of hope in the world."

President Moon Jae-in visited SK Bioscience, a COVID-19 vaccine development company located in Seongnam, Gyeonggi Province, on the afternoon of the 15th. After inspecting the research facilities, he attended the "COVID-19 Vaccine and Therapeutics Development Field Meeting."

At this meeting, President Moon reviewed the status of vaccine and treatment development through government support and corporate efforts, encouraged the researchers participating in the development and clinical trials of treatments and vaccines, and listened to difficulties and suggestions from the field.

In his opening remarks at the meeting, President Moon reiterated that "the development of vaccines and treatments is absolutely necessary to end the long battle against COVID-19."

The on-site researchers positively evaluated the government's past support efforts for COVID-19 vaccine and treatment development. They also collectively voiced that since vaccine and treatment development is highly challenging and risky, continuous support expansion rather than one-time aid is necessary.

President Moon said, "The path to the final success of vaccine and treatment development is difficult, but the experience gained from this development will be a great strength in overcoming future crises after COVID-19."

On April 9, President Moon also visited the Pasteur Institute and promised comprehensive government support for vaccine and treatment development through an on-site meeting.

President Moon Jae-in is applauding after hearing the representative remarks of Kim Eun-som, a researcher at SK Bioscience, during the "COVID-19 Vaccine and Treatment Development On-site Meeting" held at SK Bioscience in Seongnam, Gyeonggi Province, a company developing vaccines for the novel coronavirus infection (COVID-19), on the afternoon of the 15th.

Meanwhile, SK Bioscience, where the on-site meeting was held, applied for approval of Phase 1 clinical trials for its self-developed COVID-19 vaccine on the 7th. It is leading COVID-19 vaccine development by contract manufacturing vaccines from global vaccine companies such as AstraZeneca and Novavax, and is promoting a plan to supply part of the domestically produced quantity to South Korea.

This content was produced with the assistance of AI translation services.